Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
As cancer treatment improves, the cancer survivor's quality of life and level of function have gained increasing importance. Pelvic floor function is directly affected by gynecological cancer and treatment, and pelvic floor dysfunction (PFD) can severely affect a patient's life. PFD negatively affects health-related quality of life (HRQOL). Evaluation of PFD provides information about the disease burden and treatment-related effects directly from the patient's perspective and informs clinical decision-making. The pelvic floor musculature and sacral nerves are not easily accessible, and it is difficult to test them. Several functional assessments have been used to evaluate pelvic floor dysfunction; however, reports on methodology are sparse, and consensus on their use is lacking. Research on functional outcomes is highly complex and, consequently, must be addressed in a comprehensive framework.
Patients with cervical or colorectal cancer who underwent surgery or radiotherapy are recruited for the study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| pelvic floor exercise | Other | pelvic floor rehabilitation program with neuromodulation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pelvic floor rehabilitation program with neuromodulation | Behavioral | pelvic floor rehabilitation program with neuromodulation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Amplitude (uV) of motor evoked potential (MEP) evoked by magnetic stimulation on the sacral plexus. | We measure the amplitude (uV) of motor evoked potential (MEP) evoked by magnetic stimulation on the sacral plexus at the baseline and 1wk after intervention. Then we compare the change of the amplitude (1 wk after intervention-baseline)between two groups. | 1week after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| pelvic floor muscle strength(mmHg) | We measure the pelvic floor muscle strength using perometer (mmHg)at baseline and 1 wk after intervention then compare the change of pelvic floor muscle strength(1wk after intervention-baseline) between two groups. | baseline, up to 1week after intervention |
| latency (ms) of MEP (motor evoked potential) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eun Joo Yang, MD.PhD | Contact | 82-787-7734 | graceloves@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Eun Joo Yang, MD, PhD | Seoul National University Bundang Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Recruiting | Seongnam | 463-707 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
We measure the latency (ms) of MEP evoked by magnetic stimulation on the sacral plexus and compare the change of latency (1wk after intervention-baseline)between two groups |
| baseline, up to 1week after intervention |
| Functional score and symptom scale of QuEORTC QLQ-C-30,EORTC CX-24 | We evaluate the functional score and symptom scale with EORTC QLQ-C30, EORTC QLQ-CX24 questionnaires and compare the change between two groups. | baseline, up to 1week after intervention |
| Total Bladder, bowel,sexual functional scores measured by the pelvic floor questionnaire | We evaluated the bladder, bowel, sexual functional scores with the interviewer-administered pelvic floor questionnaire at baseline and 1wk after intervention then compare the change of the scores between two groups | baseline, up to 1week after intervention |
| Hiatal dimension (mm) and levator plate angle (º) on maximal pelvic floor muscle contraction measure with ultrasound | We measure the Hiatal dimension (mm) and levator plate angle (º) on maximal pelvic floor muscle contraction using ultrasound with curved transducer (3.5-6 MHz)at baseline and 1 wk after intervention and compare the change between two groups | baseline, up to 1week after intervention |